References
- Saverymutti S H, Lavender J P, Hodgson H JF, Chad-Wick V S. Assessment of disease activity in inflammatory bowel disease: a new approach using 111-In granulocyte scanning. Br Med J 1983; 287: 1751–1753
- Peters A M, Danpure H J, Osman J, et al. Clinical experience with 99m-Tc-hexamethylpropylene-amineoxime for labelling leucocytes and imaging inflammation. Lancet 1986; 2: 946–949
- Giesing D, Bighley L D, Lies R L. Effect of food and antacid on binding of sucralfate to normal and ulcerated gastric and duodenal mucosa in rats. J Clin Gastroenterol 1981; 3(suppl 2)111–116
- Dawson D J, Khan A N, Miller V, Ratcliffe J F, Shreeve D R. Detection of inflammatory bowel disease in adults and children: evaluation of a new isotopic technique. Br Med J 1985; 291: 1227–1230
- George A, Merrick M V, Palmer K R, Millar A M. 99m-Tc-sucralfate scintigraphy and colonic disease. Br Med J 1987; 295: 578
- Crama-Bohbouth G E, Arndt J W, Pena A S, et al. Is radiolabeled sucralphate scintigraphy of any use in the diagnosis of inflammatory bowel disease?. Nucl Med Commun 1988; 9: 591–595
- Dawson D J, Khan A N, Nuttal P, Shreeve D R. Technetium 99m-labelled-sucralphate isotope scanning in the detection of peptic ulceration. Nucl Med Commun 1985; 6: 319–325
- Nagashima R. Development and characteristics of sucralfate. J Clin Gastroenterol 1981; 3: 103–110